ArticlePloS one2025
Inappropriate treatment of hospital-acquired infections and associated factors among admitted adults in Wolaita Zone hospitals, Southern Ethiopia: A multi-center cross-sectional study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHospital-acquired infections (HAIs) are a global health concern. Inappropriate treatment of HAIs worsens their impact, contributing to increased antimicrobial resistance, higher healthcare costs, and heightened morbidity and mortality. However, evidence on inappropriate treatment of HAIs in resource-constrained settings remains limited. The aim of this study was to assess the prevalence and associated factors of inappropriate treatment of HAIs among admitted adults in Wolaita Zone hospitals, Southern Ethiopia.
methodsA multicenter cross-sectional study was conducted in selected hospitals in the Wolaita Zone from 28 October 2024-25 February 2025, enrolling 280 patients with HAIs. Data were collected via structured face-to-face interviews and medical record review. Data were entered in EpiData 4.6 and analyzed in SPSS 25. A binary logistic regression model was employed to examine the associations between the outcome variable and explanatory variables, with statistical significance determined at a p-value < 0.05.
resultsThe mean (± SD) age of participants was 41.25 ± 12.5 years. Pneumonia was the most frequently diagnosed HAI (133, 47.5%). Streptococcus species, Staphylococcus aureus, and Klebsiella pneumoniae were the predominant pathogens isolated. The overall prevalence of inappropriate treatment of HAI was 53.6% (95% CI: 47.5-59.5). The odds of inappropriate treatment of HAI were significantly higher in the presence of comorbidity (AOR = 2.69, 95% CI: 1.45-5.01; p = 0.002) and among patients treated in the surgical ward (AOR = 2.75, 95% CI: 1.32-5.74; p = 0.007). Conversely, culture testing (AOR = 0.34, 95% CI: 0.15-0.74; p = 0.007) and provision of clinical pharmacy service (AOR = 0.28, 95% CI: 0.13-0.60; p = 0.001) were associated with reduced odds of inappropriate treatment of HAIs.
conclusionsThe prevalence of inappropriate treatment of HAIs among admitted adults in the current study settings was high. Comorbidities, treatment ward type, culture testing, and the provision of clinical pharmacy services were significantly associated with inappropriate treatment. Clinicians should give particular attention to patients with comorbidities and those receiving care in surgical wards. Health facilities should enhance microbiological diagnostic services to promote evidence-based therapy. Additionally, clinical pharmacy services should be expanded across hospital wards to support efforts in reducing inappropriate treatment of HAIs. These findings underscore the urgent need for multifaceted interventions to improve patient care and combat antimicrobial resistance in this setting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.